Kyverna Therapeutics (KYTX) closed at $6.04 on October 20, 2026, up 3.6% from the previous close, on volume of 723,932 shares (30-day average 916,124).
Data as of October 20, 2026.
Globe Newswire (Wed, 21-Oct 7:15 AM ET)
Globe Newswire (Wed, 7-Oct 8:00 AM ET)
Globe Newswire (Thu, 24-Sep 6:00 AM ET)
Kyverna Therapeutics to Present at Upcoming Investor Conferences
Globe Newswire (Wed, 2-Sep 4:05 PM ET)
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
Globe Newswire (Tue, 11-Aug 4:02 PM ET)
Kyverna Therapeutics Secures Scalable Manufacturing for Miv-cel as BLA Submission Nears Completion
Market Chameleon (Mon, 27-Jul 7:46 AM ET)
Globe Newswire (Mon, 27-Jul 8:00 AM ET)
Market Chameleon (Wed, 22-Apr 3:05 AM ET)
Market Chameleon (Mon, 20-Apr 4:35 AM ET)
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Kyverna Therapeutics trades on the NASDAQ stock market under the symbol KYTX.
As of October 21, 2026, KYTX stock price climbed to $6.17 with 29,177 million shares trading.
KYTX has a beta of 2.05, meaning it tends to be more sensitive to market movements. KYTX has a correlation of 0.15 to the broad based SPY ETF.
KYTX has a market cap of $381.57 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that KYTX belongs to (by Net Assets): VTI, IWM, FESM, VXF, IWN.
KYTX has underperformed the market in the last year with a return of -17.7%, while the SPY ETF gained +15.9%. In the last 3 month period, KYTX fell short of the market, returning -14.8%, while SPY returned +4.1%. However, in the most recent 2 weeks KYTX has outperformed the stock market by returning +0.2%, while SPY returned -1.1%.
KYTX support price is $5.77 and resistance is $6.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KYTX shares will trade within this expected range on the day.
